Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:20 AM ET 8-K
Loan & Debt Hudson Pacific Properties, L.P. HPP

Hudson Pacific Properties $200M Debt Financing

Hudson Pacific Properties has commenced a cash tender offer to repurchase up to $200 million in aggregate principal amount of its outstanding 3.950% Senior Notes due 2027 and 5.950% Senior Notes due 2028. The company intends to fund the repurchase using cash on hand and borrowings from its unsecured revolving credit facility.

Value
$200M
8:19 AM ET 8-K
Business Update DeFi Development Corp. DFDV

DeFi Development Business Update

DeFi Development Corp. reported that its Solana (SOL) treasury grew to approximately 2.56 million SOL as of October 2, 2026, representing an 11% increase since August 12. Preliminary Q3 estimates indicate double-digit growth in SOL per share and over 100% growth in NAV per share, driven by continued SOL accumulation and the deployment of its CHAD preferred stock dividend strategy.

8:17 AM ET 8-K
M&A Deal RXO, Inc. RXO

RXO Signs $5.8B M&A Deal with C.H. Robinson Worldwide, Inc.

RXO, Inc. has entered into a definitive agreement to be acquired by C.H. Robinson in a stock-and-cash transaction with an implied value of $5.8 billion. RXO stockholders can elect to receive $30.25 in cash, 0.1992 shares of C.H. Robinson stock, or a standard combination of both per share. The deal is expected to close in the first half of 2027 and create a combined logistics company with an enterprise value exceeding $25 billion.

Value
$5.8B
Counterparty
C.H. Robinson Worldwide, Inc.
Earnings call
Oct 2, 2026, 8:00 AM ET
8:08 AM ET 8-K
M&A Deal Benitec Biopharma Inc. BNTC

Benitec Biopharma M&A Deal with U.S. Food and Drug Administration

Benitec Biopharma provided a status and timeline update for its BB-301 program following a Type C meeting with the FDA. The company remains on track to initiate a pivotal study in mid-2027, with the final study design expected to be confirmed in Q1 2027 after the FDA reviews additional natural history data.

Counterparty
U.S. Food and Drug Administration
8:07 AM ET 8-K
Capital Raise Flex Ltd. FLEX

Flex Capital Raise of $2B

Flex Ltd. entered into an agreement to sell $2.0 billion of Series A Convertible Preferred Stock in its Cloud and Power Infrastructure subsidiary, Axiom Solutions International, to a group led by General Catalyst and Koch Equity Development. The proceeds will fund Axiom's acquisition of EPC Power Corp and support its balance sheet ahead of a planned spin-off into an independent public company in Q1 2027. Flex is guaranteeing the investment, which includes a redemption obligation if the spin-off is not completed by the end of 2027.

Value
$2B
Counterparty
General Catalyst

“This investment provides equity funding for our recently announced acquisition of EPC Power and will allow Axiom to have a strong balance sheet as we prepare to stand up as an independent, publicly traded company squarely focused on the power, thermal, and compute infrastructure the AI era demands.”

Revathi Advaithi, Chief Executive Officer of Flex and expected Chief Executive Officer of Axiom

“Axiom sits at the center of the power and infrastructure buildout that AI demands, and we’ve been impressed by the team’s execution and the scale of the opportunity ahead.”

Hemant Taneja, Chief Executive Officer, General Catalyst
8:06 AM ET 8-K
Loan & Debt FTC Solar, Inc. FTCI

FTC Solar $5M Debt Financing with Acquiom Agency Services LLC

FTC Solar entered into a third amendment and limited waiver to its credit agreement, deferring a $5 million principal repayment from September 2026 to March 2027. The amendment also waives financial covenants for the remainder of 2026 and establishes new minimum revenue and EBITDA targets starting in Q1 2027. These changes provide the company with increased financial flexibility to execute its growth strategy.

Value
$5M
Counterparty
Acquiom Agency Services LLC
8:06 AM ET 8-K
Business Update Stablecoin Development Corp SDEV

Stablecoin Development Business Update

Stablecoin Development Corporation provided a preliminary update on its digital asset holdings and balance sheet for the quarter ended September 30, 2026. The company reported holding approximately 2.32 billion SKY tokens with a fair value of $180.2 million and a cash balance of $7.2 million. The update highlights the company's ongoing strategy of staking SKY tokens within the Sky Protocol, earning 34.6 million tokens in rewards during the quarter.

8:05 AM ET 8-K
Regulatory Approval Tela Bio, Inc. TELA

Tela Bio Regulatory Approval

TELA Bio received FDA 510(k) clearance for its Liora Monofilament Scaffold, a fully resorbable surgical mesh for soft tissue reinforcement. This marks a significant milestone as it is the first fully resorbable synthetic product in the company's portfolio to be designed and produced in-house.

“FDA 510(k) clearance is a significant milestone for TELA Bio as Liora is the first fully resorbable synthetic product in our portfolio to be designed and produced in-house by our team of innovative engineers.”

Heather Getz, CEO of TELA Bio
8:05 AM ET 8-K
Partnership Forum Markets Inc FRMM

Forum Markets Partnership with Edge Node Inc.

Forum Markets and Edge Node Inc. formed a joint venture, Forum Edge AI LLC, to deploy and operate high-performance inference AI compute infrastructure across the U.S. Forum holds a 51% controlling interest in the JV, which will utilize existing data centers and mobile communications tower sites to provide GPU capacity to long-term offtake partners.

Counterparty
Edge Node Inc.
8:04 AM ET 8-K
Executive Compensation Butterfly Network, Inc. BFLY

Butterfly Network Executive Compensation

Butterfly Network appointed Michael Noonen to its Board of Directors and its Compensation and Technology Committees, effective October 9, 2026. In connection with his appointment, Noonen will receive an initial grant of restricted stock units (RSUs) valued at $300,000, which will vest over three years. Noonen is a seasoned semiconductor executive who previously served as CEO of Swave Photonics and MixComm.

Counterparty
Michael Noonen
Term
until next annual meeting
8:02 AM ET Form 4
Insider Selling NXP Semiconductors N.V. NXPI

NXP Semiconductors EVP, Chief People Officer Christopher L. Jensen Sells $805K of Stock

Christopher L. Jensen, EVP, Chief People Officer, sold 3,355 shares of NXP Semiconductors N.V. at $240.00 a share, worth $805K in total on Oct 1, 2026. Shares held after the trade: 288 (-92.1%).

Value
$805K
Shares
3,355
Price
$240.00
Role
EVP, Chief People Officer
Holding change
-92.1%
Trade date
Oct 1, 2026
8:01 AM ET 8-K
Clinical Trial Data Vaxcyte, Inc. PCVX

Vaxcyte Clinical Trial Data

Vaxcyte announced positive topline results from its OPUS-1 pivotal Phase 3 trial of VAX-31, a 31-valent pneumococcal conjugate vaccine candidate for adults. The trial met all prespecified primary immunogenicity and safety endpoints, demonstrating noninferiority to Prevnar 20 and Capvaxive. These results will support a planned Biologics License Application (BLA) submission to the FDA in the first half of 2028.

Earnings call
Oct 5, 2026, 8:00 AM ET
8:01 AM ET 8-K
Investor Presentation SS Innovations International, Inc. SSII

SS Innovations International Investor Presentation

SS Innovations International, Inc. (SSII) filed an updated October 2026 Company Presentation to be used in communications with shareholders and the investment community. The presentation highlights the company's proprietary surgical robotic system, the SSi Mantra 3, and its vision for affordable surgical robotic solutions.

8:01 AM ET 8-K
Reverse Stock Split Jasper Therapeutics, Inc. JSPR

Jasper Therapeutics Reverse Stock Split

Jasper Therapeutics stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-15 and 1-for-35. Stockholders also approved increasing the total number of authorized shares of common stock from 490 million to 675 million.

8:01 AM ET 8-K
Business Update Rezolute, Inc. RZLT

Rezolute Business Update

Rezolute announced that the FDA recommended a pre-BLA meeting for ersodetug in congenital hyperinsulinism (HI) following a review of Phase 3 sunRIZE data. Although the trial missed its primary and key secondary endpoints, the Agency encouraged the meeting as a precursor to a potential Biologics License Application (BLA) submission. The company is also awaiting Phase 3 upLIFT results in tumor HI this quarter to finalize its overall regulatory strategy.

Counterparty
FDA

“We appreciate FDA’s thorough review of the extensive body of data generated in sunRIZE and are encouraged by the Agency’s recognition that this data will require in-depth evaluation during a formal BLA review.”

Nevan Charles Elam, Chief Executive Officer and Founder of Rezolute
8:00 AM ET 8-K
Other 8-K Filing Quality Industrial Corp. QIND

Quality Industrial Other 8-K Filing

Quality Industrial Corp. filed Second Amended and Restated Articles of Incorporation, which increased the authorized common stock from 450 million to 1 billion shares. The amendment also grants the Board of Directors the authority to sell or exchange substantially all of the company's assets without stockholder approval and expands liability protection to include officers. These changes were approved by Fusion Fuel Green PLC, which holds approximately 51.9% of the company's voting power.

8:00 AM ET 8-K
Capital Raise Strategy Inc MSTR

Strategy Capital Raise of $15.7M

Strategy Inc reported that between October 1 and October 4, 2026, it sold 92,894 shares of Class A Common Stock under its at-the-market (ATM) offering program for net proceeds of $15.7 million. The company utilized these proceeds, along with existing cash, to acquire 334 additional bitcoins for approximately $28.7 million, bringing its total holdings to 848,000 bitcoins.

Value
$15.7M
8:00 AM ET 8-K
Business Update Strive, Inc. ASST

Strive Business Update

Strive, Inc. provided an operational update disclosing that it purchased 2,000 bitcoin between September 28 and October 2, 2026, at an average price of $84,422 per bitcoin. As of September 30, 2026, the company held 28,000 bitcoin with a fair value of approximately $2.34 billion and total treasury value of $2.68 billion. The filing also updated the company's cash position and share counts for its Class A, Class B, and Series A Perpetual Preferred stock.

7:46 AM ET 8-K
M&A Deal Distribution Solutions Group, Inc. DSGR

Distribution Solutions Group Signs $700M M&A Deal with LKCM Headwater Investments, LLC

Distribution Solutions Group (DSG) announced a $700 million senior notes offering to fund its previously announced merger with affiliates of LKCM Headwater Investments. Under the deal, LKCM Headwater will acquire all outstanding shares of DSG it does not already own for $35.00 per share in cash, taking the company private.

Value
$700M
Counterparty
LKCM Headwater Investments, LLC
7:36 AM ET 8-K
M&A Deal Matador Resources Co MTDR

Matador Resources Signs $1.27B M&A Deal with Paloma Permian, LLC

Matador Resources Company completed its acquisition of Paloma Permian, LLC for a cash purchase price of $1.275 billion. The deal adds approximately 16,500 net acres and over 156 net drilling locations in the Delaware Basin (Eddy and Lea Counties, New Mexico). Matador paid an as-adjusted closing price of $1.255 billion and expects to integrate the assets into its existing upstream and midstream operations.

Value
$1.27B
Counterparty
Paloma Permian, LLC
7:32 AM ET 8-K
M&A Deal Harrow, Inc. HROW

Harrow Signs $30M M&A Deal with Viatris Inc.

Harrow, Inc. completed the acquisition of the dry eye disease treatment TYRVAYA from Viatris for $30 million in cash at closing. The deal includes worldwide rights except for Japan, where Viatris will pay Harrow royalties on future sales. Harrow may also pay up to $70 million in contingent milestone payments based on net sales thresholds through 2029.

Value
$30M
Counterparty
Viatris Inc.
7:23 AM ET 8-K
M&A Deal PTC Inc. PTC

PTC Signs $22.6B M&A Deal with Schneider Electric SE

PTC Inc. has entered into a definitive agreement to be acquired by Schneider Electric SE for $205 per share in an all-cash transaction. The deal values PTC's equity at approximately $22.6 billion and will result in PTC becoming a wholly owned subsidiary of Schneider Electric, creating a scaled industrial software and AI franchise.

Value
$22.6B
Counterparty
Schneider Electric SE
Earnings call
Oct 5, 2026, 9:00 AM ET

“The acquisition of PTC represents an important step forward in our ambition to lead the new era of Energy and Industrial Intelligence. Together, we are creating the industry’s most complete Software & AI powerhouse and highest-quality portfolio bridging the physical and digital worlds.”

Olivier Blum, Chief Executive Officer of Schneider Electric

“Joining Schneider Electric is an incredible opportunity to elevate the scope and impact of what we deliver for our customers globally. We gain substantial scale and resources to accelerate innovation, advance our Intelligent Product Lifecycle vision, and expand our business into more geographies and end markets to serve more customers.”

Neil Barua, President and CEO of PTC
7:21 AM ET 8-K/A
M&A Deal Processa Pharmaceuticals, Inc. PCSA

Processa Pharmaceuticals M&A Deal with Vidya Therapeutics, Inc.

Processa Pharmaceuticals filed an amendment to its 8-K to provide audited financial statements and pro forma information following its acquisition of Vidya Therapeutics. The deal adds VT7208, a CNS-penetrant BTK inhibitor, to Processa's pipeline for the treatment of autoimmune conditions like multiple sclerosis and food allergies.

Counterparty
Vidya Therapeutics, Inc.
7:20 AM ET 8-K
M&A Deal Neighborhood Intelligence, Inc. NXH

Neighborhood Intelligence M&A Deal with Fathom Holdings, Inc.

Neighborhood Intelligence and Fathom Holdings have mutually agreed to terminate their previously announced merger agreement dated June 16, 2026. Both boards concluded that current market valuations do not appropriately reflect the fair value of either company, though they intend to explore future strategic collaborations such as data sharing.

Counterparty
Fathom Holdings, Inc.
7:01 AM ET 8-K
Leadership Change Insmed Inc INSM

Insmed Leadership Change

Sara Bonstein is stepping down as Chief Financial Officer of Insmed, effective October 30, 2026, to pursue a broader leadership role. The company has initiated a search for a successor and reaffirmed its full-year 2026 revenue guidance for BRINSUPRI and ARIKAYCE.

Earnings call
Oct 29, 2026, 8:00 AM ET
7:01 AM ET 8-K
Loan & Debt Tidewater Inc TDW

Tidewater $170M Debt Financing with Banco Nacional de Desenvolvimento Econômico e Social

Tidewater Inc. amended its BNDES Construction Loans to replace legacy parent company guarantees from Wilson Sons and Remolcadores with its own corporate guarantee following its acquisition of WSUT. The amendments, effective October 1, 2026, also involved raising interest rates on the facilities to 3.21% and 3.77% respectively.

Value
$170M
Counterparty
Banco Nacional de Desenvolvimento Econômico e Social (BNDES)
7:01 AM ET 8-K
M&A Deal Advanced Drainage Systems, Inc. WMS

Advanced Drainage Systems Signs $530M M&A Deal with StormTrap Investments, L.L.C.

Advanced Drainage Systems (ADS) has entered into a definitive agreement to acquire StormTrap Investments, a leader in space-constrained stormwater solutions, for approximately $530 million. The acquisition expands ADS's addressable market in large-volume storage and is expected to be accretive to adjusted EPS in the first year. The deal will be funded through a combination of cash on hand and the company's existing credit facility.

Value
$530M
Counterparty
StormTrap Investments, L.L.C.
7:00 AM ET 8-K
Licensing Deal Alector, Inc. ALEC

Alector Licensing Deal with Genentech, Inc. Worth $100M

Alector entered into an exclusive global licensing agreement with Genentech to develop and commercialize AL050, a brain-penetrant engineered GCase enzyme replacement therapy for Parkinson’s disease. Alector will receive a $100 million upfront payment and is eligible for up to $1.17 billion in additional milestone payments plus tiered royalties on net sales. The deal extends Alector's cash runway into 2029 while allowing the company to retain ownership of its proprietary Alector Brain Carrier platform.

Value
$100M
Counterparty
Genentech, Inc.
7:00 AM ET 8-K
Investor Meeting Camping World Holdings, Inc. CWH

Camping World Holdings Investor Meeting

Camping World Holdings lowered its full-year 2026 Adjusted EBITDA guidance to below the previous range of $230 million to $270 million due to softening RV demand and margin pressure. In response, the company implemented $50 million in incremental annualized cost savings, including headcount reductions and the closure of four dealerships. The company also announced it is exploring a refinancing of its existing term loan facility to increase financial flexibility.

6:57 AM ET 8-K
Divestiture Geo Group Inc GEO

Geo Group Divestiture to United States of America for $950M

The GEO Group completed the sale of its 2,644-bed Adelanto Complex in California to the U.S. Department of Homeland Security for $950 million in gross proceeds. The company expects to receive approximately $705 million in net proceeds, which it intends to use for debt reduction and share repurchases. GEO will continue to provide support services at the facilities under an existing contract with ICE that runs through December 2034.

Value
$950M
Counterparty
United States of America (Department of Homeland Security)

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.